257-78251-39809
3 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 530 / WI
- Registered
- 2021-04-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Dose 1 — Moderna
-
2021-04-23
Dose 2 — Moderna
-
2021-04-26
Registered in v-safe
- 2021-04-26
- 2021-10-22
-
2021-11-04
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-11-07
- 2021-11-08
-
2021-12-09
Survey response — day 35, dose 3MedDRA: Lacrimation increased, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Congestion, runny nose, and teary eyesMedDRA releases: 2024-11 · check-in free text available
- 2021-12-17
- 2022-02-05
- 2022-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Moderna | |
| 2 | 2021-04-23 | Moderna | |
| 3 | 2021-11-04 | Pfizer-BioNTech | Flu |
Free text
Release 10 — day 35, dose 3
Symptoms: Congestion, runny nose, and teary eyes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Lacrimation increased | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release